Microarray pioneer Edwin Southern, biochemistry professor at Oxford University, was honored with knighthood last week on the occasion of the birthday of Queen Elizabeth II.
Peter Boatright and Tim McGrath were named to the board of directors of Lark Technologies, a Houston-based provider of genomic services, and will serve until August, when they will be eligible for election to the board. McGrath is the CEO for Houston-based Xeotron and the former president of Sigma-Genosys. Boatright is a retired attorney and a certified public accountant and serves on the boards of Guaranty Credit Card and Americrest Bank of Oklahoma City, Okla.
Robert Monaghan was named chief executive officer for Hayward, Calif.-based Zyomyx, replacing Lawrence Cohen, who moves to the position of vice chairman of the company. Monaghan previously served as president of Sigma Diagnostics, as well as its subsidiaries, and supervised the sale of the company in 2002. He also has served as a vice president of R&D at Dade Behring; vice president of sales at Behring Diagnostics; and in business development, marketing, and sales positions with: SYVA, a division of Syntex Pharmaceuticals; Ciba Corning Diagnostics; Health Charge Corporation; hospital finance consulting group Amherst Associates; and the American Hospital Supply Corporation.
Pieter Strijkert has resigned as chairman of PamGene’s supervisory board, the Hertogenbosch, Netherlands company said. Jean Deleage, a board member of the company since 2000, has been appointed interim chair. Deleage is a managing general partner and founding member of venture capital firm Alta Partners, which led PamGene’s original $6.4 million equity financing round in 2000. Deleage was previously managing partner of VC firm Burr, Egan, Deleage.